Browsing by Author Papadimitriou, C.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 1 to 20 of 42  next >
TitleAuthor(s)Issue date
All about KRAS for clinical oncology practice: gene profile, clinical implications and laboratory recommendations for somatic mutational testing in colorectal cancerLinardou, H.; Briasoulis, E.; Dahabreh, I. J.; Mountzios, G.; Papadimitriou, C.; Papadopoulos, S.; Bafaloukos, D.; Kosmidis, P.; Murray, S.24-Nov-2015
Carboplatin and Paclitaxel versus Cisplatin, Paclitaxel and Doxorubicin for first-line chemotherapy of Advanced Ovarian Cancer: A Hellenic Cooperative Oncology Group (HeCOG) studyAravantinos, G.; Fountzilas, G.; Bamias, A.; Grimani, I.; Rizos, S.; Kalofonos, H. P.; Skarlos, D. V.; Economopoulos, T.; Kosmidis, P. A.; Stathopoulos, G. P.; Briasoulis, E.; Pectasides, D.; Samantas, E.; Timotheadou, E.; Papadimitriou, C.; Papanikolaou, A.; Onyenadum, A.; Papakostas, P.; Bafaloukos, D.; Dimopoulos, M. A.24-Nov-2015
Carboplatin and Paclitaxel versus Cisplatin, Paclitaxel and Doxorubicin for first-line chemotherapy of Advanced Ovarian Cancer: A Hellenic Cooperative Oncology Group (HeCOG) studyAravantinos, G.; Fountzilas, G.; Bamias, A.; Grimani, I.; Rizos, S.; Kalofonos, H. P.; Skarlos, D. V.; Economopoulos, T.; Kosmidis, P. A.; Stathopoulos, G. P.; Briasoulis, E.; Pectasides, D.; Samantas, E.; Timotheadou, E.; Papadimitriou, C.; Papanikolaou, A.; Onyenadum, A.; Papakostas, P.; Bafaloukos, D.; Dimopoulos, M. A.24-Nov-2015
Chloranilate bridged sodium chainsPapadimitriou, C.; Veltsistas, P.; Marek, J.; Novosad, J.; Slawin, A. M. Z.; Woollins, J. D.24-Nov-2015
Displacement of triphenylphosphine from Cu(PPh3)(2)NO3 and Co(PPh3)(2)Cl-2 by a diselenoimidodiphosphinato ligand. X-ray crystal structure of (PPh3)Cu[Ph2P(Se)NP(Se)Ph-2] and Co[Ph2P(Se)NP(Se)Ph-2](2) containing the novel CuSe2P2N and CoSe2P2N inorganic metallocyclesNovosad, J.; Necas, M.; Marek, J.; Veltsistas, P.; Papadimitriou, C.; Haiduc, I.; Watanabe, M.; Woollins, J. D.24-Nov-2015
Docetaxel and cisplatin combination chemotherapy in advanced carcinoma of the urothelium: A multicenter phase II study of the Hellenic Cooperative Oncology GroupDimopoulos, M. A.; Bakoyannis, C.; Georgoulias, V.; Papadimitriou, C.; Moulopoulos, L. A.; Deliveliotis, C.; Karayannis, A.; Varkarakis, I.; Aravantinos, G.; Zervas, A.; Pantazopoulos, D.; Fountzilas, G.; Bamias, A.; Kyriakakis, Z.; Anagnostopoulos, A.; Giannopoulos, A.; Kosmidis, P.24-Nov-2015
Dose-dense sequential adjuvant chemotherapy with epirubicin, paclitaxel and CMF in high-risk breast cancerFountzilas, G.; Papadimitriou, C.; Aravantinos, G.; Nicolaides, C.; Stathopoulos, G.; Bafaloukos, D.; Kalofonos, H.; Ekonomopoulos, T.; Skarlos, D.; Pavlidis, N.; Dimopoulos, A. M.24-Nov-2015
Dose-dense sequential chemotherapy with epirubicin and paclitaxel in advanced breast cancerRazis, E.; Dimopoulos, A. M.; Bafaloukos, D.; Papadimitriou, C.; Kalogera-Fountzila, A.; Kalofonos, H.; Briassoulis, E.; Samantas, E.; Keramopoulos, A.; Pavlidis, N.; Kosmidis, P.; Fountzilas, G.24-Nov-2015
Dose-dense sequential chemotherapy with epirubicin and paclitaxel versus the combination, as first-line chemotherapy, in advanced breast cancer: a randomized study conducted by the Hellenic Cooperative Oncology GroupFountzilas, G.; Papadimitriou, C.; Dafni, U.; Bafaloukos, D.; Skarlos, D.; Moulopoulos, L. A.; Razis, E.; Kalofonos, H. P.; Aravantinos, G.; Briassoulis, E.; Papakostas, P.; Abela, K.; Gogas, E.; Kosmidis, P.; Pavlidis, N.; Dimopoulos, M. A.24-Nov-2015
Favorable outcome of ovarian germ cell malignancies treated with cisplatin or carboplatin-based chemotherapy: a Hellenic Cooperative Oncology Group studyDimopoulos, M. A.; Papadopoulou, M.; Andreopoulou, E.; Papadimitriou, C.; Pavlidis, N.; Aravantinos, G.; Aspropotamitis, A.; Anagnostopoulos, A.; Fountzilas, G.; Michalas, S.; Pectacides, D.24-Nov-2015
First line combination chemotherapy with docetaxel and vinorelbine in advanced breast cancer. A phase II studyPectasides, D.; Dimopoulos, M. A.; Aravantinos, G.; Kalophonos, H. P.; Papacostas, P.; Briasoulis, E.; Cogas, E.; Papadimitriou, C.; Skarlos, D.; Kosmidis, P.; Fountzilas, G.24-Nov-2015
First-line chemotherapy with paclitaxel by three-hour infusion and carboplatin in advanced breast cancer (final report): a phase II study conducted by the Hellenic Cooperative Oncology GroupFountzilas, G.; Dimopoulos, A. M.; Papadimitriou, C.; Kalogera-Fountzila, A.; Aravantinos, G.; Bafaloukos, D.; Athanassiades, A.; Nicolaides, C.; Keramopoulos, A.; Pavlidis, N.; Kosmidis, P.; Skarlos, D.24-Nov-2015
Ifosfamide plus oral etoposide salvage chemotherapy for platinum-resistant paclitaxel-pretreated ovarian cancerAravantinos, G.; Dimopoulos, M. A.; Kosmidis, P.; Bafaloukos, D.; Papadimitriou, C.; Kiamouris, C.; Pavlidis, N.; Sikiotis, K.; Papakostas, P.; Skarlos, D. V.24-Nov-2015
Interactions of Trivalent Lanthanide Cations with a New Hexadentate Di-Schiff Base: New Lanthanide(III) Complexes from (NE,N ' E)-2,2 '-(ethane-1,2-diylbis(oxy))bis(N-(pyridin-2-ylmethylene)ethanamine)Tsiouri, M.; Skorda, K.; Papadimitriou, C.; Li, Y.; Woollins, J. D.; Plakatouras, J. C.24-Nov-2015
Irinotecan/fluorouracil/leucovorin or the same regimen followed by oxaliplatin/fluorouracil/leucovorin in metastatic colorectal cancerKalofonos, H. P.; Papakostas, P.; Makatsoris, T.; Papamichael, D.; Vourli, G.; Xanthakis, I.; Aravantinos, G.; Papadimitriou, C.; Pentheroudakis, G.; Varthalitis, I.; Samelis, G.; Syrigos, K. N.; Xiros, N.; Stavropoulos, M.; Kosmidis, P.; Christodoulou, C.; Linardou, H.; Skondra, M.; Pectasides, D.; Economopoulos, T.; Fountzilas, G.24-Nov-2015
Lymphoma in Sjogren's syndromePavlidis, N. A.; Drosos, A. A.; Papadimitriou, C.; Talal, N.; Moutsopoulos, H. M.24-Nov-2015
Markers of bone remodeling and skeletal morbidity in patients with solid tumors metastatic to the skeleton receiving the biphosphonate zoledronic acidMountzios, G.; Terpos, E.; Syrigos, K.; Papadimitriou, C.; Papadopoulos, G.; Bamias, A.; Mavrikakis, M.; Dimopoulos, M. A.24-Nov-2015
Mechanisms of resistance to epidermal growth factor receptor tyrosine kinase inhibitors in patients with advanced non-small-cell lung cancer: clinical and molecular considerationsPallis, A.; Briasoulis, E.; Linardou, H.; Papadimitriou, C.; Bafaloukos, D.; Kosmidis, P.; Murray, S.24-Nov-2015
Metal complexes of the Schiff base ligand L=1,2-bis(2 '-pyridylmethyleneimino)benzene with Ni2+, Fe2+ and Cu2+ and their reactions with bridged bidentate ligands. The crystal structure of the complex [NiL(H2O)(2)]Cl-2Garoufis, A.; Kasselouri, S.; Mitsopoulou, C. A.; Sletten, J.; Papadimitriou, C.; Hadjiliadis, N.24-Nov-2015
Nickel(Ii) and Cobalt(Ii) Complexes of 2,4-Diaminothieno[2,3-D]-PyrimidinesTsiveriotis, P.; Varvounis, G.; Papadimitriou, C.; Hadjiliadis, N.24-Nov-2015